At the release of the Indian Pharmacopoeia 2026, the 10th edition, the government said India now ranks 8th in the world for contributions to WHO drug-safety monitoring (pharmacovigilance), up from 123rd ten years ago. The new edition adds 121 monographs, for 3,340 in all. It is the first pharmacopoeia anywhere to include monographs on blood components, with 20 of them. Nineteen Global South countries officially accept the Indian Pharmacopoeia.